Entrada Therapeutics

Entrada Therapeutics is a developer of novel therapeutics intended to treat devastating diseases.

101-250 employees
Founded 2016
$100M post ipo equity
Biotechnology
Private Company

Open Positions4

US based remote positionContractBiopharmaceuticalPosted
  • Serve as the unblinded operational lead for assigned clinical studies, ensuring all activities are conducted in compliance with ICH/GCP, regulatory requirements, and internal procedures.
  • Support and manage various study activities, including CROs, country and site selection, informed consent development and maintenance, eCRF design and implementation, protocols, study plans and manuals, IBs, CSRs.
  • Oversee study documentation, including study plans, logs, trackers, and training materials.
  • Support data review, reconciliation, and issue resolution in collaboration with Data Management, Biostatistics, and Safety teams.
  • Maintain appropriate firewalls between blinded and unblinded personnel, ensuring study integrity.
  • Provide unblinded operational updates to internal stakeholders while safeguarding treatment-related information.
  • Proactively identify and support resolution/escalation of trial conduct-related issues.
  • Participate in cross-functional meetings as the unblinded representative, escalating risks and proposing mitigation strategies.
  • Support components of site start-up, ongoing monitoring, and closeout activities.
  • Contribute to inspection readiness and support regulatory or QA requests related to unblinded processes.
Data management
Showing 1 of 4 positions

About Entrada Therapeutics

Entrada Therapeutics pioneers a new class of medicines, called EEV™ therapeutics, to deliver life-changing treatments for devastating diseases. You will find us advancing a robust portfolio of genetic medicines, particularly for Duchenne muscular dystrophy (DMD) and Myotonic Dystrophy Type 1 (DM1). Our innovative Endosomal Escape Vehicle (EEV™) platform efficiently delivers proteins, peptides, and nucleic acids into cells. This proprietary approach targets previously inaccessible intracellular targets, fundamentally transforming patient care. We are bringing these therapies to patients with high unmet medical needs. Entrada went public in 2021, raising $181.5 million, and has secured over $300 million in total funding.

How We Work

You will join a tight-knit team of experts dedicated to therapeutic development and rare diseases. We seek high-energy, dedicated colleagues ready to improve patients' lives. Our core values humanity, tenacity, creativity, collaboration, and curiosity drive our daily actions. We foster a mission-driven culture that celebrates successes and tackles challenges together. Our

Benefits & Perks

  • Comprehensive health, dental, and vision coverage
  • Life and disability insurance with a 401(k) match
  • Paid, gender-inclusive parental leave
  • Holistic health and well-being support and a $500 wellness account
  • Education reimbursement for your continued growth
  • Discretionary time off and commuting benefits
  • Health Savings Account and Dependent Care Flexible Spending Account
  • Equity and Employee Stock Purchase Plan
  • Mobile reimbursement, pet insurance, and financial coaching
  • Free drinks, snacks, company lunches, and birthday treats

Tech Stack

cmsanalyticsserverpaymentmobile

Similar Companies